Literature DB >> 28540691

Expression of MicroRNAs in Thyroid Carcinoma.

Gaohong Zhu1, Lijun Xie2, Daniel Miller3.   

Abstract

MicroRNA (miRNA) are negative regulators of gene expression and subsequent protein production. This method of action translates into regulatory control over cellular processes, including development, signaling, metabolism, and apoptosis. A broad range of miRNA are shown to have abnormal expressions in thyroid cancers which could explain the pathology of tumor oncogenesis and disease progression. A review is conducted of the current research on miRNA dysregulation in thyroid cancers, including papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), anaplastic thyroid cancer (ATC), and medullary thyroid carcinoma (MTC). Dysregulated miRNA and their associated regulatory pathways are identified and their oncogenic and pathological significance are discussed.

Entities:  

Keywords:  Gene expression; MicroRNA; Thyroid cancer

Mesh:

Substances:

Year:  2017        PMID: 28540691     DOI: 10.1007/978-1-4939-7046-9_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.

Authors:  Zhijun Zhao; Fei Yang; Yan Liu; Kai Fu; Shanghua Jing
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

2.  Bioinformatics analysis of downstream circRNAs and miRNAs regulated by Runt-related transcription factor 1 in papillary thyroid carcinoma.

Authors:  Jiajie Xu; Guowan Zheng; Haiwei Guo; Kexin Meng; Wanchen Zhang; Ru He; Chuanming Zheng; Minghua Ge
Journal:  Gland Surg       Date:  2022-05

3.  MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.

Authors:  Lei Dai; Weidong Zhang; Xianjiang Wu; Shuihong Zhou
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

4.  Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis.

Authors:  Tomoo Jikuzono; Tomoko Ishikawa; Mitsuyoshi Hirokawa; Iwao Sugitani; Osamu Ishibashi
Journal:  BMC Res Notes       Date:  2020-05-13

5.  MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP.

Authors:  Junyi Wang; Tiantian Xiao; Ming Zhao
Journal:  Onco Targets Ther       Date:  2019-09-06       Impact factor: 4.147

6.  miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8.

Authors:  Ting Liu; Jingjing Meng; Yu Zhang
Journal:  Mol Med Rep       Date:  2020-07-30       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.